Schrödinger Inc. (SDGR)
NASDAQ: SDGR
· Real-Time Price · USD
25.20
-0.43 (-1.68%)
At close: May 01, 2025, 3:08 PM
-1.68% (1D)
| Bid | 25.17 |
| Market Cap | 1.85B |
| Revenue (ttm) | 207.54M |
| Net Income (ttm) | -187.12M |
| EPS (ttm) | -2.57 |
| PE Ratio (ttm) | -9.8 |
| Forward PE | -12.29 |
| Analyst | Buy |
| Ask | 25.21 |
| Volume | 359,580 |
| Avg. Volume (20D) | 1,228,786.5 |
| Open | 25.89 |
| Previous Close | 25.63 |
| Day's Range | 24.94 - 25.77 |
| 52-Week Range | 16.60 - 28.47 |
| Beta | 1.77 |
About SDGR
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on...
Sector Healthcare
IPO Date Feb 6, 2020
Employees 891
Stock Exchange NASDAQ
Ticker Symbol SDGR
Website https://www.schrodinger.com
Analyst Forecast
According to 7 analyst ratings, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $30, which is an increase of 19.07% from the latest price.
Stock ForecastsNext Earnings Release
Schrödinger Inc. is scheduled to release its earnings on May 7, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+27.42%
Shares of healthcare technology stocks are trading...
Unlock content with
Pro Subscription
2 months ago
+2.53%
Schrodinger shares are trading higher after the company reported better-than-expected Q4 financial results.
